Current ideas about applications of heat shock proteins in vaccine design and immunotherapy

References

• Subjeck JR, Shyy TT. Stress protein systems of mammalian cells. American Journal of Physiology 1986;250:C1—C17.
   Google Scholar
• Gething MJ, Sambrook J. Protein folding in the cell. Nature 1992;355:33–45.
   PubMed Web of Science ®Google Scholar
• Lindquist S, Craig EA. The heat-shock proteins. Annual Review of Genetics 1988;22:631–677.
   PubMed Web of Science ®Google Scholar
• Rutherford SL, Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature 1998;396:336–342.
   PubMed Web of Science ®Google Scholar
• Udono H, Srivastava PK. Heat shock protein 70-associated peptides elicit specific cancer immunity. Journal of Experimental Medicine 1993;178:1391–1396.
   PubMed Web of Science ®Google Scholar
• Singh-Jasuja H, Toes RE, Spee P, Munz C, Hilf N, Schoenberger SP, Ricciardi-Castagnoli P, Neefies J, Rammensee HG, Arnold-Schild D, Schild H. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. Journal of Experimental Medicine 2000;191: 1965–1974.
   Google Scholar
• Binder RJ, Vatner R, Srivastava P. The heat-shock protein receptors: Some answers and more questions. Tissue Antigens 2004;64:442–451.
   Google Scholar
• Singh-Jasuja H, Scherer HU, Hilf N, Arnold-Schild D, Rammensee HG, Toes RE, Schild H. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. European Journal of Immunology 2000;30: 2211–2215.
   Google Scholar
• Asea A, Rehli M, Kabingu E, Boch JA, Bare 0, Auron PE, Stevenson MA, Calderwood SK. Novel signal transduction pathway utilized by extracellular H5P70: Role of toll-like receptor (TLR) 2 and TLR4. Journal of Biological Chemistry 2002;277: 15028–15034.
   Google Scholar
• Wang Y, Kelly CG, Singh M, McGowan EG, Carrara AS, Bergmeier LA, Lehner T. Stimulation of Thl-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. Journal of Immunology 2002;169: 2422–2429.
   Google Scholar
• Strbo N, Oizumi S, Sotosek-Tokmadzic V, Podack ER. Perforin is required for innate and adaptive immunity induced by heat shock protein gp96. Immunity 2003;18: 381–390.
   Google Scholar
• Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Natural Review of Immunology 2002;2:185–194.
   PubMed Web of Science ®Google Scholar
• Tamura Y, Peng P, Liu K, Daou M, Srivastava PK. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 1997;278:117–120.
   Google Scholar
• Wang XY, Kazim L, Repasky EA, Subjeck JR. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. Journal of Immunology 2001;166:490–497.
   PubMed Web of Science ®Google Scholar
• Graner MW, Zeng Y, Feng H, Katsanis E. Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunology and Immunotherapy 2003;52:226–234.
   PubMed Web of Science ®Google Scholar
• Parmiani G, Testori A, Maio M, Castelli C, Rivoltini L, Pilla L, Belli F, Mazzaferro V, Coppa J, Patuzzo R, Sertoli MR, Hoos A, Srivastava PK, Santinami M. Heat shock proteins and their use as anticancer vaccines. Clinical Cancer Research 2004;10:8142–8146.
   PubMed Web of Science ®Google Scholar
• Blachere NE, Li Z, Chandawarkar RY, Suto R, Jaikaria NS, Basu S, Udono H, Srivastava PK. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. Journal of Experimental Medicine 1997;186:1315–1322.
   PubMed Web of Science ®Google Scholar
• Moroi Y, Mayhew M, Trcka J, Hoe MH, Takechi Y, Hard FU, Rothman JE, Houghton AN. Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70. Proceedings of the National Academy of Sciences (USA) 2000;97:3485–3490.
   PubMed Web of Science ®Google Scholar
• Nicchitta CV, Carrick DM, Baker-Lepain JC. The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity. Cell Stress Chaperones 2004;9: 325–331.
   Google Scholar
• Oh HJ, Chen X, Subjeck JR. Hsp110 protects heat-denatured proteins and confers cellular thermoresistance. Journal of Biological Chemistry 1997;272: 31636–31640.
   Google Scholar
• Park J, Easton DP, Chen X, MacDonald IJ, Wang XY, Subjeck JR. The chaperoning properties of mouse grp170, a member of the third family of hsp70 related proteins. Biochemistry 2003;42:14893–14902.
   PubMed Web of Science ®Google Scholar
• Manjili MH, Henderson R, Wang XY, Chen X, Li Y, Repasky E, Kazim L, Subjeck JR. Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110. Cancer Research 200262:1737-1742.
   PubMed Web of Science ®Google Scholar
• Wang XY, Chen X, Manjili MH, Repasky E, Henderson R, Subjeck JR. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100. Cancer Research 2003;63:2553–2560.
   PubMed Web of Science ®Google Scholar
• Chen CH, Wang TL, Hung CF, Yang Y, Young RA, Pardoll DM, Wu TC. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Research 2000;60: 1035–1042.
   Google Scholar
• Huang XF, Ren W, Rollins L, Pittman P, Shah M, Shen L, Gu 0, Strube R, Hu F, Chen SY. A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccine. Cancer Research 2003;63:7321–7329.
   Google Scholar
• Suzue K, Zhou X, Eisen HN, Young RA. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proceedings of the National Academy of Sciences (USA) 1997;94:13146–13151.
   PubMed Web of Science ®Google Scholar
• Konen-Waisman S, Cohen A, Fridkin M, Cohen IR. Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection. Journal of Infectious Diseases 1999;179: 403–413.
   Google Scholar
• Ueda G, Tamura Y, Hirai I, Kamiguchi K, Ichimiya S, Torigoe T, Hiratsuka H, Sunakawa H, Sato N. Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity. Cancer Science 2004;95: 248–253.
   Google Scholar
• Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Natural Medicine 1998;4:581–587.
   PubMed Web of Science ®Google Scholar
• Wang XY, Li Y, Manjili MH, Repasky EA, Pardoll DM, Subjeck JR. Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor. Cancer Immunology and Immunotherapy 2002;51:311–319.
   PubMed Web of Science ®Google Scholar
• Zheng H, Dai J, Stoilova D, Li Z. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. Journal of Immunology 2001;167:6731–6735.
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Nguyen T, Podack ER. Cutting edge: Tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. Journal of Immunology 1999;163: 5178–5182.
   Google Scholar